Label: SENNA-S- senna and docusate sodium tablets, 8.6 mg and 50 mg tablet, coated
-
NDC Code(s):
69517-131-02,
69517-131-05,
69517-131-10,
69517-131-24, view more69517-131-25, 69517-131-50
- Packager: HealthLife of USA LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 21, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
- Uses
-
Warnings
Do not use
- if you are now taking mineral oil, unless directed by a doctor
- laxative products for longer than 1 week unless directed by a doctor
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that lasts over 2 weeks
-
Directions
take preferably at bedtime or as directed by a doctor
- adults and children 12 years of age or older- starting dosage:2 tablets once a day, maximum dosage:4 tablets twice a day
- children 6 to under 12 years- starting dosage:1 tablet once a day, maximum dosage:2 tablets twice a day
- children 2 to under 6 years- starting dosage:1/2 tablet once a day, maximum dosage:1 tablet twice a day
- children under 2 years- starting dosage:ask a doctor, maximum dosage:ask a doctor
- Other information
- Inactive ingredients
-
Questions or comments?
Call toll free 1-844-832-1138 Monday through Friday 9AM – 5PM EST or www.healthlifeofusa.com
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
SENNA-S
senna and docusate sodium tablets, 8.6 mg and 50 mg tablet, coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69517-131 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 50 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP) D&C YELLOW NO. 10 (UNII: 35SW5USQ3G) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HYPROMELLOSES (UNII: 3NXW29V3WO) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) MAGNESIUM STEARATE (UNII: 70097M6I30) MALTODEXTRIN (UNII: 7CVR7L4A2D) POLYETHYLENE GLYCOL 1000 (UNII: U076Q6Q621) STEARIC ACID (UNII: 4ELV7Z65AP) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color orange Score no score Shape ROUND Size 10mm Flavor Imprint Code S35 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69517-131-25 25 in 1 BOX 04/08/2016 1 2 in 1 POUCH; Type 0: Not a Combination Product 2 NDC:69517-131-50 50 in 1 BOX 04/08/2016 2 2 in 1 POUCH; Type 0: Not a Combination Product 3 NDC:69517-131-02 2 in 1 POUCH 04/08/2016 3 2 in 1 POUCH; Type 0: Not a Combination Product 4 NDC:69517-131-10 1000 in 1 BOTTLE 04/08/2016 4 NDC:69517-131-05 500 in 1 BOTTLE 4 NDC:69517-131-24 24 in 1 BOTTLE 4 1 in 1 CARTON; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug 505G(a)(3) 03/07/2016 Labeler - HealthLife of USA LLC (079656178) Establishment Name Address ID/FEI Business Operations Elysium Pharmaceutical Ltd. 915664486 manufacture(69517-131)